IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux
- Zhang Y. , et al.
2. Lapatinib-Based Radioagents for Application in Nuclear Medicine
- Koźmiński P. , et al.
3. A review of recombinant HER3 affibodies with an effective diagnostic view of cancer cells
- Babaei Khorzoughi S. , et al.
4. The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer
- Molavipordanjani S. , et al.